322 related articles for article (PubMed ID: 36030569)
1. Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare professional stakeholders.
Ruiz AS; Fontaine G; Patey AM; Grimshaw JM; Presseau J; Cox J; Dussault C; Kronfli N
Int J Drug Policy; 2022 Nov; 109():103837. PubMed ID: 36030569
[TBL] [Abstract][Full Text] [Related]
2. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
[TBL] [Abstract][Full Text] [Related]
3. Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: A model-based cost-effectiveness analysis.
Duchesne L; Dussault C; Godin A; Maheu-Giroux M; Kronfli N
Int J Drug Policy; 2021 Oct; 96():103345. PubMed ID: 34176704
[TBL] [Abstract][Full Text] [Related]
4. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.
Crowley D; Van Hout MC; Murphy C; Kelly E; Lambert JS; Cullen W
Health Justice; 2018 Dec; 6(1):23. PubMed ID: 30569249
[TBL] [Abstract][Full Text] [Related]
6. Mapping the Theoretical Domain Framework to the Consolidated Framework for Implementation Research: do multiple frameworks add value?
O'Donovan B; Kirke C; Pate M; McHugh S; Bennett K; Cahir C
Implement Sci Commun; 2023 Aug; 4(1):100. PubMed ID: 37620981
[TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators to COVID-19 vaccine acceptability among people incarcerated in Canadian federal prisons: A qualitative study.
Lessard D; Ortiz-Paredes D; Park H; Varsaneux O; Worthington J; Basta NE; MacDonald SE; Lebouché B; Cox J; Ismail SJ; Kronfli N
Vaccine X; 2022 Apr; 10():100150. PubMed ID: 35243324
[TBL] [Abstract][Full Text] [Related]
8. Improving the quality of self-management support in ambulatory cancer care: a mixed-method study of organisational and clinician readiness, barriers and enablers for tailoring of implementation strategies to multisites.
Howell D; Powis M; Kirkby R; Amernic H; Moody L; Bryant-Lukosius D; O'Brien MA; Rask S; Krzyzanowska M
BMJ Qual Saf; 2022 Jan; 31(1):12-22. PubMed ID: 33727415
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of HCV in prisons in Wales, UK and the impact of moving to opt-out HCV testing.
Perrett SE; Plimmer A; Shankar AG; Craine N
J Public Health (Oxf); 2020 May; 42(2):423-428. PubMed ID: 32090269
[TBL] [Abstract][Full Text] [Related]
10. An opt-out approach to hepatitis C virus testing in English prisons: the literature underpinning the policy.
Jack K
Br J Nurs; 2021 Nov; 30(20):1158-1164. PubMed ID: 34761976
[TBL] [Abstract][Full Text] [Related]
11. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
Rance J; Lafferty L; Treloar C;
Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
[TBL] [Abstract][Full Text] [Related]
12. Barriers and enablers to physical activity in patients during hospital stay: a scoping review.
Geelen SJG; van Dijk-Huisman HC; de Bie RA; Veenhof C; Engelbert R; van der Schaaf M; Lenssen AF
Syst Rev; 2021 Nov; 10(1):293. PubMed ID: 34736531
[TBL] [Abstract][Full Text] [Related]
13. Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.
Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N;
Int J Drug Policy; 2024 Apr; 126():104386. PubMed ID: 38492433
[TBL] [Abstract][Full Text] [Related]
14. Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health.
Morris MD; Brown B; Allen SA
Int J Prison Health; 2017 Sep; 13(3-4):192-199. PubMed ID: 28914118
[TBL] [Abstract][Full Text] [Related]
15. Common barriers and enablers to the use of non-drug interventions for managing common chronic conditions in primary care: an overview of reviews.
Greenwood H; Davidson AR; Thomas R; Albarqouni L
BMC Prim Care; 2024 Apr; 25(1):108. PubMed ID: 38582829
[TBL] [Abstract][Full Text] [Related]
16. Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination.
Kronfli N; Dussault C; Bartlett S; Fuchs D; Kaita K; Harland K; Martin B; Whitten-Nagle C; Cox J
Can Liver J; 2021; 4(3):292-310. PubMed ID: 35992251
[TBL] [Abstract][Full Text] [Related]
17. Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.
Crowley D; Van Hout MC; Lambert JS; Kelly E; Murphy C; Cullen W
Harm Reduct J; 2018 Dec; 15(1):62. PubMed ID: 30538000
[TBL] [Abstract][Full Text] [Related]
18. Developing theory-informed knowledge translation strategies to facilitate the use of patient-reported outcome measures in interdisciplinary low back pain clinical practices in Quebec: mixed methods study.
Eilayyan O; Visca R; Zidarov D; Ware P; Bussières A; Ahmed S
BMC Health Serv Res; 2020 Aug; 20(1):789. PubMed ID: 32843032
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.
Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C;
Int J Drug Policy; 2021 Dec; 98():103379. PubMed ID: 34311138
[TBL] [Abstract][Full Text] [Related]
20. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
Evrard P; Pétein C; Beuscart JB; Spinewine A
Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
